News
Phase 1 and 2 Human Trials Reveal Safety and immunogenicity of the ChAdOx1 nCoV-19 Vaccine
09-28-2020 / Phase 1 and 2 Human Trials Reveal Safety and immunogenicity of the ChAdOx1 nCoV-19 Vaccine
Read More
News
Studies show that the RBD is the best antigen to induce neutralizing antibodies for COVID-19
07-19-2020 / The spike (S) glycoprotein of the coronavirus SARS-CoV-2 is responsible for viral entry into human cells by directly binding the angiotensin-converting enzyme 2 (ACE2) expressed on the cell surface by many cell types.
Read More Blog
Shining a Spotlight on Malaria
11-21-2019 / In September this year, Kenya made history by becoming the first country to launch the world’s first ever malaria vaccine pilot program.
Read More News
Novartis' breakthrough rabbit-derived mAb receives FDA approval
10-21-2019 / People with the chronic, degenerative eye disease wet age-related macular degeneration (AMD) now have a new, potentially better, treatment option to choose from.
Read More Resource
Identifying new therapeutic leads for spinal cord injury using a zebrafish screening platform
07-30-2019 / Identifying new therapeutic leads for spinal cord injury using a zebrafish screening platform
Read More News
Albino lizards result from pioneering use of CRISPR-Cas9 genome-editing in reptiles
04-22-2019 / Evidence for Enduring Neurogenesis in Adult Brains
Read More News
Destroying NETs that hide bacteria as a way to treat acute bacterial meningitis
04-15-2019 / Destroying NETs that hide bacteria as a way to treat acute bacterial meningitis
Read More News
Evidence for Enduring Neurogenesis in Adult Brains
04-03-2019 / Evidence for Enduring Neurogenesis in Adult Brains
Read More